Traumatic brain injury (TBI) in humans as an incredibly heterogeneous disease and the significant effort involved in developing and characterizing reproducible and clinically-relevant models of specific types of TBI has enabled the neurotrauma research community to begin to identify important and injury-specific mechanisms of cell death and dysfunction. This application revolves around the general hypotheses that selective molecular and cellular pathways are activated or initiated which are injury-specific mechanisms of cell death and are activated or initiated which are injury-specific. Through the sue of selective experimental models that closely simulate the major classes of human TBI, we can better understand and characterize the pathological sequelae of clinical head injury and explore novel mechanistic-based therapies. We have chosen to focus on several exciting areas, including (1) the relationship between TBI and the cellular events associated with Alzheimer's and other neurodegenerative disease, (2) the role of the dysfunctional cytoskeleton and calpain-mediated cytoskeletal proteolysis in post- traumatic neuronal death and damage, and (3) the activation of cell death enzymes such as MAP kinases and caspases and their role in post- traumatic cell death. We will continue to forge mechanistic links between these pathological cascades and outcome following TBI. We will also evaluate (4) the important role of secondary hypoxia/ischemia in the exacerbation of cellular injury and the association with one or more of the pathologic mechanisms studied in these Projects. Finally, we will use the accumulated molecular and cellular information to design and drive novel neuroprotective strategies to enhance recovery of function and attenuate neuronal cell death. These projects will be significantly supported by human/histopathology, biomechanics, molecular biology, and administrative cores. We believe that the understanding of the specific cellular and molecular mechanisms underlying cell death and dysfunction is critically important to the continuation of scientific progress in this field and to the development of novel therapeutic strategies targeted to treat human brain injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS008803-29
Application #
6393241
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Program Officer
Michel, Mary E
Project Start
1976-08-01
Project End
2005-08-31
Budget Start
2001-09-01
Budget End
2002-08-31
Support Year
29
Fiscal Year
2001
Total Cost
$1,457,407
Indirect Cost
Name
University of Pennsylvania
Department
Neurosurgery
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Nariai, Hiroki; Duberstein, Susan; Shinnar, Shlomo (2018) Treatment of Epileptic Encephalopathies: Current State of the Art. J Child Neurol 33:41-54
Nariai, Hiroki; Beal, Jules; Galanopoulou, Aristea S et al. (2017) Scalp EEG Ictal gamma and beta activity during infantile spasms: Evidence of focality. Epilepsia 58:882-892
Tomasevic, Gregor; Laurer, Helmut L; Mattiasson, Gustav et al. (2012) Delayed neuromotor recovery and increased memory acquisition dysfunction following experimental brain trauma in mice lacking the DNA repair gene XPA. J Neurosurg 116:1368-78
Browne, Kevin D; Chen, Xiao-Han; Meaney, David F et al. (2011) Mild traumatic brain injury and diffuse axonal injury in swine. J Neurotrauma 28:1747-55
Tomasevic, Gregor; Raghupathi, Ramesh; Scherbel, Uwe et al. (2010) Deletion of the p53 tumor suppressor gene improves neuromotor function but does not attenuate regional neuronal cell loss following experimental brain trauma in mice. J Neurosci Res 88:3414-23
Hånell, Anders; Clausen, Fredrik; Björk, Maria et al. (2010) Genetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice. J Neurotrauma 27:1297-309
Marklund, N; Morales, D; Clausen, F et al. (2009) Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice. Neuroscience 163:540-51
Marklund, Niklas; Bareyre, Florence M; Royo, Nicolas C et al. (2007) Cognitive outcome following brain injury and treatment with an inhibitor of Nogo-A in association with an attenuated downregulation of hippocampal growth-associated protein-43 expression. J Neurosurg 107:844-53
Keck, Carrie A; Thompson, Hilaire J; Pitkanen, Asla et al. (2007) The novel antiepileptic agent RWJ-333369-A, but not its analog RWJ-333369, reduces regional cerebral edema without affecting neurobehavioral outcome or cell death following experimental traumatic brain injury. Restor Neurol Neurosci 25:77-90
Serbest, Gulyeter; Burkhardt, Matthew F; Siman, Robert et al. (2007) Temporal profiles of cytoskeletal protein loss following traumatic axonal injury in mice. Neurochem Res 32:2006-14

Showing the most recent 10 out of 71 publications